Literature DB >> 17487555

Medication use and the risk of breast cancer.

Scott Davis1, Dana K Mirick.   

Abstract

PURPOSE: To investigate whether the use of commonly-prescribed medications, primarily antihypertensives and antidepressants, is associated with an increased risk of breast cancer.
METHODS: Participants from a population-based case-control study were re-contacted 5-8 years after the original study regarding prescription and non-prescription medication use during the 10 years prior to diagnosis. Controls (n = 647) were frequency-matched to the cases (n = 600) by 5-year age groups. Medication use information was obtained during a telephone interview, and participants were sent the questionnaire in advance to facilitate recall. Odds ratios and 95% confidence intervals were estimated using conditional logistic regression.
RESULTS: A slightly increased risk of breast cancer was associated with use of calcium channel blockers (CCBs), but there was no trend with increasing duration or recency of use. Breast cancer risk was not associated with use of antidepressants, beta blockers, corticosteroids, or non-steroidal anti-inflammatory drugs. Results were similar when analyses were restricted to cases with localized disease.
CONCLUSIONS: These results support previous findings that CCBs may be associated with modest increases in breast cancer risk, but not findings that non-steroidal anti-inflammatory use reduces risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487555     DOI: 10.1007/s10654-007-9135-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   12.434


  33 in total

1.  Residential magnetic fields and the risk of breast cancer.

Authors:  Scott Davis; Dana K Mirick; Richard G Stevens
Journal:  Am J Epidemiol       Date:  2002-03-01       Impact factor: 4.897

2.  Breast cancer risk in a large cohort of female antidepressant medication users.

Authors:  Reina Haque; Shelley M Enger; Wansu Chen; Diana B Petitti
Journal:  Cancer Lett       Date:  2005-04-18       Impact factor: 8.679

3.  Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.

Authors:  Eric J Jacobs; Michael J Thun; Cari J Connell; Carmen Rodriguez; S Jane Henley; Heather S Feigelson; Alpa V Patel; W Dana Flanders; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

4.  Psychotropic medication use and risk of hormone-related cancers: the New York University Women's Health Study.

Authors:  I Kato; A Zeleniuch-Jacquotte; P G Toniolo; A Akhmedkhanov; K Koenig; R E Shore
Journal:  J Public Health Med       Date:  2000-06

5.  Calcium channel blockers and the risk of cancer.

Authors:  L Rosenberg; R S Rao; J R Palmer; B L Strom; P D Stolley; A G Zauber; M E Warshauer; S Shapiro
Journal:  JAMA       Date:  1998-04-01       Impact factor: 56.272

6.  Cancer risk of hypertensive patients taking calcium antagonists.

Authors:  D J Hole; C R Gillis; I R McCallum; G T McInnes; P L MacKinnon; P A Meredith; L S Murray; J W Robertson; A F Lever
Journal:  J Hypertens       Date:  1998-01       Impact factor: 4.844

7.  Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.

Authors:  Christopher I Li; Kathleen E Malone; Noel S Weiss; Denise M Boudreau; Kara L Cushing-Haugen; Janet R Daling
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

8.  Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.

Authors:  Trista W Johnson; Kristin E Anderson; DeAnn Lazovich; Aaron R Folsom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

9.  Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.

Authors:  Mary Beth Terry; Marilie D Gammon; Fang Fang Zhang; Heba Tawfik; Susan L Teitelbaum; Julie A Britton; Kotha Subbaramaiah; Andrew J Dannenberg; Alfred I Neugut
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

10.  The effects of tricyclic antidepressants on breast cancer risk.

Authors:  C R Sharpe; J-P Collet; E Belzile; J A Hanley; J-F Boivin
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more
  16 in total

1.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

Authors:  Amal Melhem-Bertrandt; Mariana Chavez-Macgregor; Xiudong Lei; Erika N Brown; Richard T Lee; Funda Meric-Bernstam; Anil K Sood; Suzanne D Conzen; Gabriel N Hortobagyi; Ana-Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

Review 2.  The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives.

Authors:  Demetrios Moris; Michalis Kontos; Eleftherios Spartalis; Ian S Fentiman
Journal:  Breast Care (Basel)       Date:  2016-10-24       Impact factor: 2.860

3.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

4.  Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.

Authors:  Deirdre P Cronin-Fenton; Lars Pedersen; Timothy L Lash; Søren Friis; John A Baron; Henrik T Sørensen
Journal:  Breast Cancer Res       Date:  2010-03-01       Impact factor: 6.466

Review 5.  Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry.

Authors:  Lisa Cosgrove; Ling Shi; David E Creasey; Maria Anaya-McKivergan; Jessica A Myers; Krista F Huybrechts
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

6.  Breast cancer recurrence risk in relation to antidepressant use after diagnosis.

Authors:  Jessica Chubak; Diana S M Buist; Denise M Boudreau; Mary Anne Rossing; Thomas Lumley; Noel S Weiss
Journal:  Breast Cancer Res Treat       Date:  2007-12-06       Impact factor: 4.872

7.  Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yuxiu Xie; Men Wang; Peng Xu; Yujiao Deng; Yi Zheng; Si Yang; Ying Wu; Zhen Zhai; Dai Zhang; Na Li; Nan Wang; Jing Cheng; Zhijun Dai
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

8.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

9.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082

Review 10.  Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression.

Authors:  Ebbe Boedtkjer
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.